BACKGROUND The academia-industry interface is important, and, despite challenges that inevitably occur, bears the potential for positive synergies to emerge. Perceived barriers to wider collaboration in academia-industry oncology research in Europe need to be addressed, current academic cooperative group and industry models for collaboration need to be discussed, and a common terminology to facilitate understanding of both sectors' concerns needs to be established with an eye towards improving academia-industry partnerships on clinical trials for the benefit of patients with cancer. METHODOLOGY CAREFOR (Clinical Academic Cancer Research Forum), a multi-stakeholder platform formed to improve the direction for academic clinical trial...
Research question: What are the best theories of collaboration for conducting academic-industry coll...
The pharmaceutical and device industry has greatly contributed to diagnostic and therapeutic approac...
Clinical research is conducted by academia, cooperative groups (CGs) or pharmaceutical industry. Her...
ObjectivesThe aim of this study was to deliver insights from multiple stakeholders into actual and f...
Background: Academic research is important to face unmet medical needs. The Oncological community en...
International/intercontinental collaboration is necessary to set up new innovative clinical trials f...
Collaboration between academia and industry has been the focus of numerous government reports and in...
Background: New technologies and techniques in radiation oncology and imaging offer opportunities to...
The acceleration of technological change, public policy, economic forces, and increased collaboratio...
Academic; Radiopharmaceuticals; Regulatory in EuropeAcadèmic; Radiofàrmacs; Regulador a EuropaAcadém...
AbstractClinical research has evolved substantially over the last two decades, but industry-sponsore...
The way academic institutions and pharmaceutical companies have been approaching collaborations has ...
Academic, industry, regulatory leaders and patient advocates in cancer clinical research met in Nove...
The value of collaborations and partnerships between different stakeholders to achieve optimum outco...
Collaboration can be challenging; nevertheless, the emerging successes of large, multi-partner, mult...
Research question: What are the best theories of collaboration for conducting academic-industry coll...
The pharmaceutical and device industry has greatly contributed to diagnostic and therapeutic approac...
Clinical research is conducted by academia, cooperative groups (CGs) or pharmaceutical industry. Her...
ObjectivesThe aim of this study was to deliver insights from multiple stakeholders into actual and f...
Background: Academic research is important to face unmet medical needs. The Oncological community en...
International/intercontinental collaboration is necessary to set up new innovative clinical trials f...
Collaboration between academia and industry has been the focus of numerous government reports and in...
Background: New technologies and techniques in radiation oncology and imaging offer opportunities to...
The acceleration of technological change, public policy, economic forces, and increased collaboratio...
Academic; Radiopharmaceuticals; Regulatory in EuropeAcadèmic; Radiofàrmacs; Regulador a EuropaAcadém...
AbstractClinical research has evolved substantially over the last two decades, but industry-sponsore...
The way academic institutions and pharmaceutical companies have been approaching collaborations has ...
Academic, industry, regulatory leaders and patient advocates in cancer clinical research met in Nove...
The value of collaborations and partnerships between different stakeholders to achieve optimum outco...
Collaboration can be challenging; nevertheless, the emerging successes of large, multi-partner, mult...
Research question: What are the best theories of collaboration for conducting academic-industry coll...
The pharmaceutical and device industry has greatly contributed to diagnostic and therapeutic approac...
Clinical research is conducted by academia, cooperative groups (CGs) or pharmaceutical industry. Her...